Lemoite et al. showed that in patients with NAFLD the adiponectin:leptin ratio is inversely related to the severity of NAFLD and proposed as predictive factor of NASH67. Here, ADIPOQ is linked to metabolic dysfunction-associated steatotic liver disease.